Protagonist Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.About PTGX
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.
PTGX Key Statistics
Stock Snapshot
The current Protagonist Therapeutics(PTGX) stock price is $109.78, with a market capitalization of 7.06B. The stock trades at a price-to-earnings (P/E) ratio of -60.86.
On 2026-06-12, Protagonist Therapeutics(PTGX) stock traded between a low of $109.60 and a high of $111.78. Shares are currently priced at $109.78, which is +0.2% above the low and -1.8% below the high.
Protagonist Therapeutics(PTGX) shares are trading with a volume of 445.25K, against a daily average of 689.6K.
In the last year, Protagonist Therapeutics(PTGX) shares hit a 52-week high of $111.78 and a 52-week low of $49.38.
In the last year, Protagonist Therapeutics(PTGX) shares hit a 52-week high of $111.78 and a 52-week low of $49.38.
PTGX News
...
New insider activity at Protagonist Therapeutics ( (PTGX) ) has taken place on June 11, 2026. Director William Waddill of Protagonist Therapeutics has cashed o...
Analyst ratings
93%
of 14 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.